Skip to main content
HCAT
NASDAQ Technology

Health Catalyst Proposes Board Declassification, Details Executive Severance Amid Restructuring

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Health Tech Stocks · Healthcare
Sentiment info
Neutral
Importance info
8
Price
$1.27
Mkt Cap
$93.845M
52W Low
$0.955
52W High
$4.291
52W Position info
33% above low
Off High info
70% below high
Rel. Volume info
0.8× avg
Market data snapshot near publication time

HCAT sits 33% above its 52-week low of $0.955.

Summary

Health Catalyst proposes to declassify its board, enhancing shareholder rights, while also disclosing significant severance payments to former executives as part of ongoing restructuring efforts.


Key Events · Corporate Governance and Compliance · HCAT

  • Board Declassification Proposed

    Shareholders will vote on a proposal to phase out the classified board structure, moving to annual director elections for all directors starting with the 2029 Annual Meeting. This follows an advisory approval in 2025.

  • Significant Executive Severance Packages

    Former Chief Commercial Officer Kevin Freeman received approximately $696,833 in cash, health benefits, and accelerated equity vesting. Former Chief Operating Officer Dan LeSueur received approximately $691,211 in cash, health benefits, and accelerated equity vesting. These payouts total approximately $1.38 million.

  • Board Size Reduction and Refreshment

    The board is being reduced from seven to six directors, with Matthew Kolb not standing for re-election. The company has also added three new independent directors and appointed a new CEO since the beginning of 2025.

  • Related Party Transactions and Voting Agreement

    The company has ongoing technology and professional service relationships with Carle Health, a non-profit hospital network where a former director served as COO, generating $17.7 million in revenue in 2025. Additionally, a voting agreement with First Light Asset Management (a 17.4% owner) and Director Mathew Arens requires them to vote in line with board recommendations, with exceptions.


Analysis · HCAT · Technology

Health Catalyst is seeking shareholder approval to declassify its board, transitioning to annual director elections by 2029, a move generally favored by governance advocates. This comes as the company continues a significant restructuring, including a recent 9% workforce reduction and executive leadership changes. The filing details substantial severance packages for two departing executives, totaling approximately $1.38 million, which represents a notable financial outflow for a company of this market capitalization, especially in the context of recent significant net losses and goodwill impairment.

How filings like this one have moved

In the 30 days to Nov 17, 2026, 48.3% of the 2133 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.28%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, HCAT was trading at $1.27 on NASDAQ in the Technology sector, with a market capitalization of approximately $93.8M. The 52-week trading range was $0.96 to $4.29. This filing was assessed with neutral market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

HCAT - Latest Insights

HCAT
Nov 05, 2026, 5:17 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $1.50
Real-time Price: $1.31 info
Change: -$0.190 (-13%) info
Market Cap: $99.764M info
HCAT
Nov 05, 2026, 4:03 PM EST
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $1.50
Real-time Price: $1.31 info
Change: -$0.190 (-13%) info
Market Cap: $99.764M info
HCAT
Sep 08, 2026, 5:04 PM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
7
Price at Filing: $1.70
Real-time Price: $1.31 info
Change: -$0.390 (-23%) info
Market Cap: $99.764M info
HCAT
Sep 08, 2026, 8:13 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $1.63
Real-time Price: $1.31 info
Change: -$0.320 (-20%) info
Market Cap: $99.764M info
HCAT
Aug 06, 2026, 4:09 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $1.67
Real-time Price: $1.31 info
Change: -$0.360 (-22%) info
Market Cap: $99.764M info